{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36239588", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "20"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "20"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "10", "Day": "14"}], "ELocationID": ["10.23736/S2724-5276.22.07063-X"], "Journal": {"ISSN": "2724-5780", "JournalIssue": {"Volume": "74", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Dec"}}, "Title": "Minerva pediatrics", "ISOAbbreviation": "Minerva Pediatr (Torino)"}, "ArticleTitle": "Safety and tolerability of ozonated-oils in liposome eyedrop in preterm eye examination.", "Pagination": {"StartPage": "733", "EndPage": "737", "MedlinePgn": "733-737"}, "Abstract": {"AbstractText": ["Eye examinations for ROP screening in preterm newborns are characterized by two main problems: infection control and poor tear secretion. Therefore, in order to reduce the risk of ocular infection and to protect the ocular surface, netilmicin eye drops are usually used after the exams. The purpose of our study was to evaluate the safety and tolerability of ozonated-oils eyedrops during the eye examination of preterm babies in the screening for ROP, sparing the use of antibiotics eyedrops.", "All newborn infants that needed to be screened for ROP were divided into two groups: in group A we used topical netilmicin eye drops and in group B ozonated-oils eyedrops. We looked for any sign of conjunctival injection and chemosis, infectious conjunctivitis, blepharoconjunctivitis, erythema, and edema of the eyelids.", "A total of 162 adverse effects out of 3546 examinations (4,5%) were reported acutely: in group A (1778 examinations), they consisted of 47 reactive conjunctivitis, 3 cases of blepharoconjunctivitis, 30 of eyelids swelling, and 3 infectious conjunctivitis, compared to 39 cases of conjunctival injection, 3 blepharoconjunctivitis, 33 eyelids swelling and 4 infectious conjunctivitis in group B (1768 examinations). No significant differences were found in the comparison of the two groups.", "Ozonated-oils eyedrops should be considered a valid and safe alternative for the lubrification of the ocular surface and an adjuvant strategy to further minimize the risk of microbial contamination during screening for ROP."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Citt\u00e0 della Salute e della Scienza, Turin, Italy - matteo_scaramuzzi@hotmail.com."}], "LastName": "Scaramuzzi", "ForeName": "Matteo", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Neonatology and NICU, Sant'Anna Hospital, Citt\u00e0 della Salute e della Scienza, Turin, Italy."}], "LastName": "Maestri", "ForeName": "Andrea", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Neonatology and NICU, Sant'Anna Hospital, Citt\u00e0 della Salute e della Scienza, Turin, Italy."}], "LastName": "Campagnoli", "ForeName": "Maria F", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neonatal Care Unit, Department of Public Health and Paediatric, University of Turin, Turin, Italy."}], "LastName": "Coscia", "ForeName": "Alessandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Citt\u00e0 della Salute e della Scienza, Turin, Italy."}, {"Identifier": [], "Affiliation": "Department of Surgical Science, Eye Clinic, University of Turin, Turin, Italy."}], "LastName": "Reibaldi", "ForeName": "Michele", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Minerva Pediatr (Torino)", "NlmUniqueID": "101777303", "ISSNLinking": "2724-5780"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ophthalmic Solutions"}, {"RegistryNumber": "0", "NameOfSubstance": "Liposomes"}, {"RegistryNumber": "4O5J85GJJB", "NameOfSubstance": "Netilmicin"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Infant"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Infant, Newborn"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ophthalmic Solutions"}, {"QualifierName": [], "DescriptorName": "Liposomes"}, {"QualifierName": [], "DescriptorName": "Netilmicin"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Conjunctivitis"}, {"QualifierName": [], "DescriptorName": "Oils"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2022", "Month": "10", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "14", "Hour": "9", "Minute": "44"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36239588", "10.23736/S2724-5276.22.07063-X", "S2724-5276.22.07063-X"]}}], "PubmedBookArticle": []}